'Never Buy A Drug Stock Just For The Yield': Jim Cramer On This Big Pharma Company
Portfolio Pulse from Lisa Levin
Jim Cramer, on CNBC's 'Mad Money Lightning Round', recommended selling Petróleo Brasileiro S.A. - Petrobras (PBR) and Fisker Inc. (FSR). He expressed concerns about AutoNation, Inc. (AN) and Bristol-Myers Squibb Company (BMY), but did not recommend selling them. He also mentioned that Iridium Communications Inc. (IRDM) is expected to lose money.
October 24, 2023 | 12:47 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Jim Cramer recommended selling Fisker Inc. (FSR).
Jim Cramer's recommendation to sell FSR could lead to a short-term decrease in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Jim Cramer mentioned that Iridium Communications Inc. (IRDM) is expected to lose money.
Jim Cramer's statement that IRDM is expected to lose money could lead to a short-term decrease in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Jim Cramer recommended selling Petróleo Brasileiro S.A. - Petrobras (PBR) as the stock has run too much.
Jim Cramer's recommendation to sell PBR could lead to a short-term decrease in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEUTRAL IMPACT
Jim Cramer expressed concerns about AutoNation, Inc. (AN) but did not recommend selling the stock.
Jim Cramer's concerns about AN could create uncertainty among investors, but his decision not to recommend selling the stock could mitigate any potential short-term impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEUTRAL IMPACT
Jim Cramer expressed concerns about Bristol-Myers Squibb Company (BMY) but did not recommend selling the stock.
Jim Cramer's concerns about BMY could create uncertainty among investors, but his decision not to recommend selling the stock could mitigate any potential short-term impact.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100